Elekta (OTCMKTS:EKTAY) Issues Earnings Results

Elekta (OTCMKTS:EKTAY – Get Free Report) issued its quarterly earnings data on Thursday. The company reported $0.07 EPS for the quarter, Zacks reports. Elekta had a positive return on equity of 11.11% and a negative net margin of 3.32%.

Elekta Price Performance

Elekta stock opened at $5.69 on Thursday. The stock’s fifty day moving average price is $5.18 and its two-hundred day moving average price is $5.71. Elekta has a one year low of $4.35 and a one year high of $6.93. The company has a debt-to-equity ratio of 0.47, a current ratio of 0.87 and a quick ratio of 0.68. The firm has a market cap of $2.10 billion, a PE ratio of -35.56 and a beta of 1.01.

Get Elekta alerts:

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded shares of Elekta from a “strong sell” rating to a “hold” rating in a research note on Tuesday, July 28th. One research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Reduce”.

View Our Latest Analysis on Elekta

Elekta Company Profile

(Get Free Report)

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.

Further Reading

• Five stocks we like better than Elekta
• Is Quantinuum Emerging as a Leader in the Quantum Race?
• J.M. Smucker’s Rally Nears a Key Test: Is a Full Recovery Ahead?
• Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
• Alcoa’s Gallium Project Opens a New Door Beyond Aluminum

Receive News & Ratings for Elekta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elekta and related companies with MarketBeat.com's FREE daily email newsletter.